Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Thomas

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Circulation|June 23, 2018
Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery DiseaseRachel C Orme, William A E Parker, Mark R Thomas, et al.
Blood|August 26, 2022
S100A8/A9 drives the formation of procoagulant platelets through GPIbαMartina Colicchia, Waltraud C Schrottmaier, Gina Perrella, et al.
Blood Advances|July 5, 2024
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in miceChristopher W Smith, Joana Campos, Helena C Brown, et al.
JAMA|December 13, 2021
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
JAMA|September 11, 2023
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Circulation|June 23, 2018
Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery DiseaseRachel C Orme, William A E Parker, Mark R Thomas, et al.
Blood|August 26, 2022
S100A8/A9 drives the formation of procoagulant platelets through GPIbαMartina Colicchia, Waltraud C Schrottmaier, Gina Perrella, et al.
Blood Advances|July 5, 2024
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in miceChristopher W Smith, Joana Campos, Helena C Brown, et al.
JAMA|December 13, 2021
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
JAMA|September 11, 2023
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
Pageof 8